BOCA PHARMA LLC
GenericsBOCA PHARMA LLC is a generic drug manufacturer focused on Dermatology.
BOCA PHARMA LLC's Key Drugs
BOCA PHARMA LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
BOCA PHARMA LLC's Recent FDA Approvals
New NDA/BLA approvals for BOCA PHARMA LLC over the last two years — novel drugs only, excluding generics and label supplements.
BOCA PHARMA LLC's Therapeutic Areas
BOCA PHARMA LLC's approved drugs and pipeline span 1 therapeutic area, led by Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
BOCA PHARMA LLC's Top Competitors
BOCA PHARMA LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
BOCA PHARMA LLC Pipeline Snapshot
Active clinical trials for BOCA PHARMA LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1989-01-11
- Latest
- 2007-04-03
- Applications
- 2